Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product

PURPOSE: To evaluate the efficacy and safety of the biosimilar infliximab in adult patients with inflammatory arthritis switched from reference product in our center. PATIENTS AND METHODS: In April 2014, patients attending our rheumatology service for infliximab infusions were switched from referenc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Access Rheumatol
Auteurs principaux: Abdalla, Abuelmagd, Byrne, Niamh, Conway, Richard, Walsh, Thomas, Mannion, Geraldine, Hanly, Michael, O’Sullivan, Miriam, Curran, Ann Maria, Carey, John J
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349501/
https://ncbi.nlm.nih.gov/pubmed/28331376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S124975
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires